The recent crackdown by the Maharashtra FDA on so-called “cheese analogue” products raises an uncomfortable question—what took so long?
For years now, the market has been quietly, and sometimes not so quietly, flooded with products that mimic dairy—cheese, paneer, cream—without actually being dairy. Let’s call it what it is: imitation. Or more precisely, analogue. And analogue, by definition, is not dairy. It is not derived from milk, does not follow the compositional standards of dairy, and certainly does not have the legitimacy to be marketed using dairy nomenclature.
So when we hear terms like “cheese analogue” or “paneer analogue,” we must pause. These are not technically valid categories. There is cheese. There is paneer. And then there are non-dairy products. Blurring this distinction is not just a semantic issue—it is a deliberate greying of consumer understanding.
The Maharashtra FDA’s action is therefore welcome—but also overdue.
Why now?
This is not a new issue. Many of us have been consistently raising concerns across platforms—blogs, interviews, panel discussions, and even YouTube conversations. The stance has always been clear and consistent: we are not against analogue products. Innovation in food is inevitable and often necessary. But innovation cannot come at the cost of transparency.
The problem is not the existence of analogues. The problem is the appropriation of dairy identity.
When a consumer buys “cheese,” they are not signing up for a vegetable oil-based formulation dressed up in dairy clothing. When a restaurant uses such products without disclosure, it moves from a question of labeling to one of integrity.
And that is where this issue transcends food safety and nutrition. It becomes a matter of trust.
Another question emerges: why is this action limited to Maharashtra?
If the concern is valid—and it clearly is—then why is enforcement not uniform across India? Is the rest of the country immune to this issue? Or are we witnessing a fragmented regulatory response where action depends more on geography than on principle?
Consistency in enforcement is as important as the regulation itself. Otherwise, we risk creating pockets of compliance and vast stretches of ambiguity.
There is also the matter of regulatory intent versus execution.
There has already been discussion at the government level about restricting the manufacture of such analogue products to licensed entities. A move that, on paper, seems logical. If these products are to exist, they must at least be traceable, accountable, and produced under defined standards.
Dr. K. Rathnam, CEO, Milky Mist says “We welcome the Maharashtra FDA’s directive mandating clear disclosure of cheese analogues. This is a progressive step towards enhancing transparency and empowering consumers to make informed choices about what they consume. As India’s largest paneer manufacturer, Milky Mist has always stood for authenticity and quality — our paneer is made from 100% pure milk, with no substitutes or shortcuts.
This move will help distinguish genuine dairy products from analogues, ensuring a level playing field for organised players like Milky Mist who are committed to delivering authentic paneer to consumers. It also reinforces trust in the dairy ecosystem and strengthens food integrity across the industry.”
But where does that stand today?
Why has this not been implemented with the urgency it deserves?
When regulations are announced but not enforced, they do little more than signal intent without delivering impact. And in the meantime, the market continues to evolve—often faster than the regulatory framework meant to govern it.
A clarification that cannot be ignored
The recent enforcement notice itself reveals a deeper confusion. It explicitly flags the “suspected usage of cheese analogue as paneer” in restaurants and goes on to state that selling cheese analogue as paneer is a “grave violation.” It even mandates that usage of such products must be disclosed on menus.
But this raises a more fundamental issue.
Cheese analogue and paneer are not interchangeable mislabels—they are entirely different product constructs being imitated separately. What is being used in place of paneer is not “cheese analogue” in the literal sense, but a paneer substitute—typically made using palm oil, starch, and non-dairy proteins like soya. Similarly, high-cost cheese used in pizzas and continental dishes is often replaced with a different category of analogue products formulated to mimic cheese functionality.
By collapsing everything into “cheese analogue being used as paneer,” are we missing the larger picture?
This is not just about paneer dishes being misrepresented. This extends equally—if not more—to premium cheese-based offerings where substitution goes largely unquestioned.
More importantly, even the usage of the term “cheese analogue” itself needs scrutiny. As per regulatory thinking, an analogue is a non-dairy product. It should not carry dairy prefixes. You cannot attach dairy identity to something that fundamentally does not belong to that category.
In fact, there have already been deliberations at the regulatory level to move away from such terminology altogether. Stakeholders have been asked to suggest alternative names for products currently masquerading as paneer but made from palm oil, starch, and soya protein.
Which brings us back to the core issue: nomenclature is not a technicality—it defines consumer perception.
If the name itself is misleading, everything that follows is compromised.
So are we correcting the problem—or merely scratching the surface?
This is not about being for or against a category of products. It is about clarity. It is about honesty in labeling. It is about ensuring that consumers are not left navigating a grey zone where what they see is not necessarily what they get.
At its core, this is about integrity in the food system.
And perhaps that is the larger conversation we need to have.
Some questions worth putting on the table:
- Why did it take so long for authorities to act on a practice that has been visible for years?
- Why is enforcement currently limited to Maharashtra—what about the rest of India?
- Are we oversimplifying the issue by focusing only on paneer substitution while ignoring high-value cheese analogues?
- Should products that are not dairy be allowed to use dairy-linked terminology in any form?
- What is the status of the proposed restriction on manufacturing by non-licensed entities—and why the delay?
- If even regulatory communication uses terms like “cheese analogue,” are we inadvertently legitimising a misleading category?
- Most importantly, are we doing enough to ensure that consumers are not misled, even unintentionally?
Because in the end, this is not just about what is being sold.
It is about what is being implied.
Source : Article by Kuldeep Sharma April 24th 2026 Dairynews7x7